Azithromycin

Treatment for Chlamydial Infection

Typical Dosage: 1g orally in a single dose

Effectiveness
97%
Safety Score
70%
Clinical Trials
47
Participants
1.5M

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
1g orally in a single dose
Time to Effect
Single dose for cure, symptoms improve in days
Treatment Duration
Single dose
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1.03(Treat 1.03 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15
Monitoring:$600
Side Effect Mgmt:$5
Total Annual:$620
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$20.62
Cost per Remission
$20.62
Comparison vs Doxycycline
Cost Difference
$-5/year
Less expensive
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$-9,777
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$45/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$15/year
Potential OTC Price
$7/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Azithromycin Outcomes

for Chlamydial Infection

Efficacy Outcomes
Overall Effectiveness
+97%
Response Rate
+97%
Remission Rate
+97%
Common Side Effects
Nausea
+10%
Diarrhea
+8%
Abdominal pain
+5%
Vomiting
+3%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
16 completed trials for Azithromycin in Chlamydial Infection

YCFM (Youth Correctional Facilities Males)

NCT03249935COMPLETEDPHASE2
View Study
100 participants
INTERVENTIONAL
Los Angeles, United States
Started: Aug 24, 2017

Treatment Failure of Chlamydial Infection in Males and Females in Youth Correctional Facilities

NCT00980148COMPLETEDPHASE3
View Study
567 participants
INTERVENTIONAL
Birmingham, United States +1 more
Started: Dec 1, 2009

The Effect of Oral Azithromycin in the Treatment of Chlamydial Conjunctivitis

NCT01178762COMPLETEDNA
View Study
42 participants
INTERVENTIONAL
Taipei, Taiwan
Started: Sep 1, 2007

Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM

NCT03608774COMPLETEDPHASE4
View Study
177 participants
INTERVENTIONAL
Boston, United States +1 more
Started: Jul 13, 2018

Chlamydia Trachomatis Immunology and Vaccinology Study

NCT01150747COMPLETED
View Study
347 participants
OBSERVATIONAL
Pittsburgh, United States +3 more
Started: Jan 1, 2011

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

NCT00618449COMPLETEDPHASE4
View Study
1.14K participants
INTERVENTIONAL
San Francisco, United States +1 more
Started: Jan 1, 2008

Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women

NCT01631201COMPLETEDPHASE2
View Study
82 participants
INTERVENTIONAL
Birmingham, United States +4 more
Started: Jul 1, 2012

Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT

NCT03862495COMPLETEDNA
View Study
200 participants
INTERVENTIONAL
Guangzhou, China +1 more
Started: May 21, 2020

Tripartite International Research for the Elimination of Trachoma

NCT01202331COMPLETEDPHASE4
View Study
29K participants
INTERVENTIONAL
Addis Ababa, Ethiopia
Started: Nov 1, 2010

Trachoma Elimination Follow-up

NCT00221364COMPLETEDPHASE4
View Study
20K participants
INTERVENTIONAL
Addis Ababa, Ethiopia
Started: Mar 1, 2003

Trachoma Amelioration in Northern Amhara (TANA)

NCT00322972COMPLETEDPHASE4
View Study
33K participants
INTERVENTIONAL
Addis Ababa, Ethiopia
Started: Jun 1, 2006

Incubation Time and Test of Cure of Chlamydia Trachomatis

NCT01448876COMPLETED
View Study
52 participants
OBSERVATIONAL
Geleen, Netherlands
Started: Jun 1, 2009

Partnership for Rapid Elimination of Trachoma

NCT00792922COMPLETEDPHASE4
View Study
128 participants
INTERVENTIONAL
San Francisco, United States +2 more
Started: May 1, 2008

Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

NCT00043264COMPLETEDPHASE2
View Study
40 participants
INTERVENTIONAL
Houston, United States

Expedited Partner Therapy for MSM in Peru

NCT01720654COMPLETEDNA
View Study
165 participants
INTERVENTIONAL
Lima, Peru
Started: Aug 1, 2012

Azithromycin Reduction to Reach Elimination of Trachoma

NCT04185402COMPLETEDPHASE4
View Study
74.9K participants
INTERVENTIONAL
Niamey, Niger
Started: May 29, 2021
Showing 20 of 47 total trials